Perspective of cytokine regulation for periodontal treatment: Fibroblast biology

Shogo Takashiba, Koji Naruishi, Yoji Murayama

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Efforts to understand the pathogenesis of periodontal diseases have been underway for decades. Studies of immunological aspects in addition to the structural components of gingival fibroblasts showed that the fibroblasts actively participate in immune and inflammatory events in periodontal diseases. Future strategies for the prevention and treatment of periodontal diseases should biologically regulate fibroblast activities. These cells are surrounded by monocyte-derived proinflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and,lymphocyte-derived interleukin-6 (IL-6) in inflamed gingival tissue. Recent anti-cytokine therapy for inflammatory diseases including rheumatoid arthritis aimed to inhibit the binding of cytokines to targeted cells such as fibroblasts and condrocytes. IL-1β and TNF-α are thought to be therapeutic targets because these cytokines are essential for the initiation of inflammatory immune reactions and are produced for prolonged periods in inflammatory diseases. IL-6 is also a target, because it is abundantly present in inflammatory fesions and activates fibroblasts in the presence of soluble IL-6 receptor. In addition, these cytokines accelerate gingival fibroblasts to produce collagenolytic enzymes, resulting in tissue destruction. Soluble receptors for IL-1β and TNF-α are suggested to be candidates for therapeutic molecules, but soluble receptor for IL-6 is suggested to be a factor-stimulating fibroblast. This paper will review the utilization of soluble receptors specific to inflammatory cytokines which potentially stimulate fibroblasts to regulate biological events involved in the pathogenesis of periodontal diseases.

Original languageEnglish
Pages (from-to)103-110
Number of pages8
JournalJournal of Periodontology
Volume74
Issue number1
DOIs
Publication statusPublished - Jan 1 2003

Fingerprint

Fibroblasts
Cytokines
Periodontal Diseases
Interleukin-1beta
Interleukin-6 Receptors
Tumor Necrosis Factor-alpha
Interleukin-6
Utilization Review
Monocytes
Rheumatoid Arthritis
Therapeutics
Lymphocytes
Enzymes

Keywords

  • Cytokines
  • Fibroblasts
  • Immune response
  • Interleukin-1β
  • Interleukin-6
  • Periodontal diseases/pathogenesis

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Perspective of cytokine regulation for periodontal treatment : Fibroblast biology. / Takashiba, Shogo; Naruishi, Koji; Murayama, Yoji.

In: Journal of Periodontology, Vol. 74, No. 1, 01.01.2003, p. 103-110.

Research output: Contribution to journalArticle

@article{e26a9798327142608c6d119e835f5069,
title = "Perspective of cytokine regulation for periodontal treatment: Fibroblast biology",
abstract = "Efforts to understand the pathogenesis of periodontal diseases have been underway for decades. Studies of immunological aspects in addition to the structural components of gingival fibroblasts showed that the fibroblasts actively participate in immune and inflammatory events in periodontal diseases. Future strategies for the prevention and treatment of periodontal diseases should biologically regulate fibroblast activities. These cells are surrounded by monocyte-derived proinflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and,lymphocyte-derived interleukin-6 (IL-6) in inflamed gingival tissue. Recent anti-cytokine therapy for inflammatory diseases including rheumatoid arthritis aimed to inhibit the binding of cytokines to targeted cells such as fibroblasts and condrocytes. IL-1β and TNF-α are thought to be therapeutic targets because these cytokines are essential for the initiation of inflammatory immune reactions and are produced for prolonged periods in inflammatory diseases. IL-6 is also a target, because it is abundantly present in inflammatory fesions and activates fibroblasts in the presence of soluble IL-6 receptor. In addition, these cytokines accelerate gingival fibroblasts to produce collagenolytic enzymes, resulting in tissue destruction. Soluble receptors for IL-1β and TNF-α are suggested to be candidates for therapeutic molecules, but soluble receptor for IL-6 is suggested to be a factor-stimulating fibroblast. This paper will review the utilization of soluble receptors specific to inflammatory cytokines which potentially stimulate fibroblasts to regulate biological events involved in the pathogenesis of periodontal diseases.",
keywords = "Cytokines, Fibroblasts, Immune response, Interleukin-1β, Interleukin-6, Periodontal diseases/pathogenesis",
author = "Shogo Takashiba and Koji Naruishi and Yoji Murayama",
year = "2003",
month = "1",
day = "1",
doi = "10.1902/jop.2003.74.1.103",
language = "English",
volume = "74",
pages = "103--110",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "1",

}

TY - JOUR

T1 - Perspective of cytokine regulation for periodontal treatment

T2 - Fibroblast biology

AU - Takashiba, Shogo

AU - Naruishi, Koji

AU - Murayama, Yoji

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Efforts to understand the pathogenesis of periodontal diseases have been underway for decades. Studies of immunological aspects in addition to the structural components of gingival fibroblasts showed that the fibroblasts actively participate in immune and inflammatory events in periodontal diseases. Future strategies for the prevention and treatment of periodontal diseases should biologically regulate fibroblast activities. These cells are surrounded by monocyte-derived proinflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and,lymphocyte-derived interleukin-6 (IL-6) in inflamed gingival tissue. Recent anti-cytokine therapy for inflammatory diseases including rheumatoid arthritis aimed to inhibit the binding of cytokines to targeted cells such as fibroblasts and condrocytes. IL-1β and TNF-α are thought to be therapeutic targets because these cytokines are essential for the initiation of inflammatory immune reactions and are produced for prolonged periods in inflammatory diseases. IL-6 is also a target, because it is abundantly present in inflammatory fesions and activates fibroblasts in the presence of soluble IL-6 receptor. In addition, these cytokines accelerate gingival fibroblasts to produce collagenolytic enzymes, resulting in tissue destruction. Soluble receptors for IL-1β and TNF-α are suggested to be candidates for therapeutic molecules, but soluble receptor for IL-6 is suggested to be a factor-stimulating fibroblast. This paper will review the utilization of soluble receptors specific to inflammatory cytokines which potentially stimulate fibroblasts to regulate biological events involved in the pathogenesis of periodontal diseases.

AB - Efforts to understand the pathogenesis of periodontal diseases have been underway for decades. Studies of immunological aspects in addition to the structural components of gingival fibroblasts showed that the fibroblasts actively participate in immune and inflammatory events in periodontal diseases. Future strategies for the prevention and treatment of periodontal diseases should biologically regulate fibroblast activities. These cells are surrounded by monocyte-derived proinflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and,lymphocyte-derived interleukin-6 (IL-6) in inflamed gingival tissue. Recent anti-cytokine therapy for inflammatory diseases including rheumatoid arthritis aimed to inhibit the binding of cytokines to targeted cells such as fibroblasts and condrocytes. IL-1β and TNF-α are thought to be therapeutic targets because these cytokines are essential for the initiation of inflammatory immune reactions and are produced for prolonged periods in inflammatory diseases. IL-6 is also a target, because it is abundantly present in inflammatory fesions and activates fibroblasts in the presence of soluble IL-6 receptor. In addition, these cytokines accelerate gingival fibroblasts to produce collagenolytic enzymes, resulting in tissue destruction. Soluble receptors for IL-1β and TNF-α are suggested to be candidates for therapeutic molecules, but soluble receptor for IL-6 is suggested to be a factor-stimulating fibroblast. This paper will review the utilization of soluble receptors specific to inflammatory cytokines which potentially stimulate fibroblasts to regulate biological events involved in the pathogenesis of periodontal diseases.

KW - Cytokines

KW - Fibroblasts

KW - Immune response

KW - Interleukin-1β

KW - Interleukin-6

KW - Periodontal diseases/pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=0037268875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037268875&partnerID=8YFLogxK

U2 - 10.1902/jop.2003.74.1.103

DO - 10.1902/jop.2003.74.1.103

M3 - Article

C2 - 12593604

AN - SCOPUS:0037268875

VL - 74

SP - 103

EP - 110

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 1

ER -